Intensity. Enhanced R&D Intensive Support is open to an SME (fewer than 500 staff, and turnover of no more than €100 million or a balance sheet of no more than €86 million, counting linked and partner businesses) that is loss-making and spends at least 30% of its total expenditure on qualifying R&D. It pays up to about 27p for each £1 of qualifying spend, compared with about 16p under the merged scheme, and a company that qualifies can still choose the merged scheme instead. Run the calculation before you choose a route. The costs of connected companies count towards the test, which matters for a spinout that sits within a group.
Where the work happened. For accounting periods beginning on or after 1 April 2024, payments to subcontractors for R&D done outside the UK are excluded, and so are payments for externally provided workers whose pay is not subject to UK PAYE. The company's own employees working abroad are not affected. The exception is work that needs conditions the UK does not have, such as geography, the environment, a specialist test facility or a legal or regulatory requirement, where it would be wholly unreasonable to replicate them here. Cost and the availability of workers do not count. Companies with a registered office in Northern Ireland that claim the intensive route are not subject to the restriction. Instead, their relief under that route is limited to €300,000 over three years for most businesses. Those with no trade in goods and no electricity market activity can opt out, which brings the restriction back and removes the limit. If a fabrication partner abroad does part of your development, check the position before the claim is prepared.